Search
Free Newsletters
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Editions
Español
Deutsch
Français
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
About
Editions
Español
Deutsch
Français
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
MSFT
-0.92%
$390.43
-$3.62
GOOGL
-1.57%
$157.64
-$2.52
NYT
+0.23%
$51.74
+$0.12
FOXA
-0.75%
$49.26
-$0.37
WBD
-2.74%
$8.53
-$0.24
MCD
+0.89%
$317.30
+$2.80
AMZN
-2.87%
$182.02
-$5.38
CMCSA
+0.03%
$33.95
+$0.01
META
-2.36%
$541.37
-$13.07
UAL
-0.79%
$68.39
-$0.55
MSFT
-0.92%
$390.43
-$3.62
GOOGL
-1.57%
$157.64
-$2.52
NYT
+0.23%
$51.74
+$0.12
FOXA
-0.75%
$49.26
-$0.37
WBD
-2.74%
$8.53
-$0.24
MCD
+0.89%
$317.30
+$2.80
AMZN
-2.87%
$182.02
-$5.38
CMCSA
+0.03%
$33.95
+$0.01
META
-2.36%
$541.37
-$13.07
UAL
-0.79%
$68.39
-$0.55
Markets
RECENT NEWS
Prelude Therapeutics Incorporated (PRLD) reports earnings
March 10, 2025
Advertisement